Clinical Edge Journal Scan

Clinical Edge Journal Scan

Insights on comparative efficacy of tirzepatide and semaglutide in T2D

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

T2D: Meta-analysis suggests superiority of tirzepatide over other glucose lowering therapies

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

OGTT prognostic for T2D risk in nulliparous pregnant women testing negative for GD

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

Metformin combination therapy tops metformin monotherapy in untreated T2D

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

T2D: Cardiovascular and safety outcomes associated first-line SGLT-2i vs. metformin

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

Once-weekly dulaglutide improves glycemic control in youths with T2D

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

Commentary: New Treatments in T2D and Potential New Benefits From Metformin, June 2022

Publish date: June 1, 2022

• Read More

Clinical Edge Journal Scan

No effect of red meat diet on T2D risk factors, says meta-analysis

Publish date: May 24, 2022

• Read More

Clinical Edge Journal Scan

Cotadutide is safe and effective in overweight and obese T2D patients

Publish date: May 24, 2022

• Read More

Clinical Edge Journal Scan

Metformin may protect against age-related macular degeneration in T2D

Publish date: May 24, 2022

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »